Global Hyaluronic Acid-based Dermal Fillers Market Overview

Global Hyaluronic Acid-based Dermal Fillers Market Size Was Valued at USD 4.91 Billion in 2023 and is Projected to Reach USD 8.49 Billion by 2032, Growing at A CAGR of 6.2 % From 2024 to 2032.

Dermal fillers based on hyaluronic acid, also known as hyaluronan, are made from a clear material produced naturally in the human body. Hyaluronic acid is a form of sugar (polysaccharide) found in bodily tissues like skin and cartilage. When in gel form, it can react with water and swell, giving it a smoothing/filling effect. Bacteria or rooster combs are two sources of hyaluronic acid utilized in dermal fillers (avian). Hyaluronic acid used in dermal fillers is sometimes chemically changed (crosslinked) to extend its life in the body. This material's effects last for about 6 to 12 months. This acid is also a humectant, which means it may retain moisture: In water, it can bind up to 1,000 times its volume. Its capacity to pull in and retain water enhances the volumizing impact while also adding hydration, making it a tempting treatment as a dermal filler. To restore lost volume, smooth wrinkles and fine lines, and increase volume and plumpness, hyaluronic acid fillers are injected into the skin with a needle or cannula. The effects of the treatment might be seen right away.

Dermal fillers are injectable procedures that help reduce the appearance of lines, wrinkles, and furrows caused by aging. They can also revitalize the face by adding volume to the lips, cheeks, chin, and other areas. Because of its adaptability, efficacy, and lack of side effects, hyaluronic acid is a preferred choice among injectable fillers. Existing market players are focused on constant innovation and up-gradation of their product portfolio with new and efficient product offerings to provide patients with better and more accurate aesthetic outcomes. The increasing desire for aesthetic beauty, driven by the less-invasive nature of the treatments and the increasing efficiency of hyaluronic acid-based dermal fillers, is one of the key factors driving the global hyaluronic acid-based dermal fillers market.

Market Dynamics And Factors For Hyaluronic Acid-based Dermal Fillers Market

Drivers:

Rising Demand for Minimally Invasive Facial Treatment

Considering the developments in cosmetic treatments, a growing number of consumers are opting for operations that are less invasive and less unpleasant. In comparison to Botox, which lasts three to six months, the effects of hyaluronic acid dermal fillers can last for six to twelve months. Consumers prefer hyaluronic acid fillers to alternative injectables for cosmetic and aesthetic treatments because they have fewer side effects and last longer. Facial rejuvenation treatments have come a long way from equipment-based procedures, from minimally invasive injectables to non-invasive topical skin treatments, further complementing the growing adoption of facial rejuvenation treatments among patients with specific cosmetic concerns, the most common of which is anti-aging.

Growing Infrastructure Development Across Developing Countries

During the projected period, the market for Hyaluronic Acid-based Dermal Fillers will be supported by an expanding network of healthcare institutions that provide advanced aesthetic treatments and improved infrastructure. In recent years, both industrialized and developing countries have seen a considerable increase in the number of facilities such as clinics, medical spas, and rejuvenation centers. As a result, the business will increase due to the fast adoption of various non-invasive therapies given by these facilities, which have advantages such as cost-effectiveness and shorter treatment times. Furthermore, the growing number of trained experts, such as dermatologists, will help the business grow even faster.

Restraints:

COVID-19 Pandemic Is Barriers for The Growth of The Market

Due to restrictions on movement and lockdown in the majority of locations around the world, the pandemic has had a stronger influence on aesthetic medicine and cosmetic dermatology. Furthermore, as economies have slowed, discretionary spending has decreased, limiting customers' ability to undergo costly aesthetic operations. The market for Hyaluronic Acid-based Dermal Fillers have been constrained since the number of cosmetic treatments has decreased. However, market recovery will be aided by high demand and accompanying drop of COVID-19 instances.

Opportunities:

Demand for the Dermal Filler Injection

The unique location is the number one reason patients seek dermal filler injections, according to a recent assessment by plastic surgeons. Puffiness and darker skin beneath the eyes make us appear exhausted, and no amount of pricey lotions or serums will usually help. Hyaluronic Acid-based Dermal Fillers, on the other hand, can help provide volume to depressed eye regions and alleviate puffiness. The results are natural-looking, long-lasting, and instantaneous, as with other dermal filler injections.

Dermal Fillers based on hyaluronic acid have always been popular for cheeks, but today's popular cheek fillers are far more natural-looking. Patients wanting cheek dermal filler injections are more likely to request a subtle look, such as filling in parts of the cheeks that have flattened with time or giving the appearance of higher cheekbones. Dermal filler injections, a relatively new kid on the block, are gaining favor among patients wishing to sculpt their faces with modest modifications. Dermal Fillers based on Hyaluronic Acid are highly successful at making modest alterations in the angularity of the jawline for a sophisticated style that's gaining popularity.

Segmentation Analysis of Hyaluronic Acid-based Dermal Fillers Market

By Product, the single-phase fillers segment is anticipated to observe profitable growth due to different applications in skin and facial aesthetic procedures, comparatively fewer side effects, and rapid technological development for emerging new fillers. Dermatologists and customers favor single-phase solutions for the treatment of soft tissue facial abnormalities because the uncross-linked HA promotes elastin and collagen production, giving the face a youthful and healthy-looking shine. Single-phase goods do not go through the sizing technique, which breaks down the gel, throughout the production process. In the production of single-phase dermal fillers like Juvederm Ultra, Hylacross technology is used, resulting in product life and desirable effects.

By Application, the lip augmentation segment is anticipated to hold the largest Hyaluronic Acid-based Dermal Fillers market share throughout the forecast period. Dermal Fillers based on hyaluronic acid are widely utilized for lip augmentation operations around the world. It should be noted that hyaluronic acid aids in the volume increase of the lips. First-time filler patients are frequently prescribed hyaluronic acid-based dermal fillers. The duration of these fillers is usually 6 to 18 months. Hyaluronic Acid fillers also provide the lips form, volume, and structure, which is why they are so popular. During the projection period, such factors are expected to boost the segment's expansion.

By End-User, Specialty & Dermatology Clinics segment is expected to dominate the Hyaluronic Acid-based Dermal Fillers market over the forecast period. Over the projected period, advancements in hyaluronic acid-based dermal filler technologies for wrinkle treatment, together with rising spending on cosmetic operations, are expected to drive market expansion.

Regional Analysis of Hyaluronic Acid-based Dermal Fillers Market

With its well-established healthcare infrastructure, favorable policies, and the growing number of plastic surgery treatments, North America is expected to have a considerable market share. The United States has the biggest number of plastic surgeons (7,009) in the world, according to the International Society of Aesthetic Plastic Surgery. In 2018, 17.7 million surgical and minimally invasive plastic surgery procedures were performed in the United States, according to the American Society of Plastic Surgeons. Furthermore, the widespread use of plastic surgery and minimally invasive plastic surgery methods is predicted to stimulate regional development.

The rise in awareness of hyaluronic acid-based dermal fillers and the increasing demand for aesthetics in emerging nations such as India and China are propelling growth in the hyaluronic acid-based dermal fillers market in Asia Pacific region during the forecast period. New goods are being launched in nations like China and India as a result of the methods utilized by important market leaders. Due to the availability of sophisticated hyaluronic acid-based dermal fillers and the high proportion of the senior population in Japan, there is a significant demand for these dermal fillers.

Factors such as a rapidly aging population and increased public knowledge of advanced aesthetic procedures are driving the European industry. The Russian dermal fillers market is being boosted by increased demand for minimally invasive procedures, the rising use of non-surgical dermal fillers, and the commercialization of novel interventional solutions. Over the projection period, the Russian market is expected to rise steadily. The country's sales are predicted to grow because of an aging population and the widespread use of hyaluronic acid-based dermal fillers. Growth in the German market has been enabled by the introduction of new products and the development of distribution.

Brazil, Mexico, Argentina, Colombia, Chile, Peru, and the Rest of South America make up the market for hyaluronic acid-based dermal fillers in South America. Over the projection period, the market in Brazil is expected to hold the greatest market share among these nations. The increasing availability of diverse filler choices, as well as the increased desire for non-surgical procedures, can be contributed to the market's rise in the country. Furthermore, the increased awareness of skin tightening procedures among the country's aging population is expected to add to the market's growth in Brazil. According to World Bank figures, the number of people aged 65 and more in the country climbed from 9,175,089 in 2000 to 19,525,475 in 2019.

COVID-19 Impact Analysis on Hyaluronic Acid-based Dermal Fillers Market

COVID-19 is an infectious disease with no specific and approved treatment. On the other hand, global Hyaluronic Acid-based dermal filler manufacturers are finding it difficult to manufacture and distribute products across borders due to lockdown, disrupted supply chains, and social distancing restrictions. The global healthcare system has been impacted by the Coronavirus pandemic as a result of the region's high debt levels and already poor economies. COVID-19 has a significant impact on the market for Hyaluronic Acid-based dermal fillers, which are now beginning to be felt. As frontline healthcare workers are involved in critical procedures and the containment of COVID-19 dissemination, a variety of issues have an indirect impact on the dermal filler market. Flight cancellations travel bans, mass quarantine, as well as mounting public terror, and concern about the future, are just a few of the additional elements at play. Due to the pandemic, there is a delay in fulfilling the end product orders due to various types of difficulties faced by the manufacturers. Even though demand for Restylane was typical during the pandemic, the company did not cease producing it, according to the lead reply from Gladerma Laboratories LLC. Manufacturers are also being compelled to find new contract manufacturers and suppliers as a result of the coronavirus disease (COVID-19) pandemic outbreak, which has pushed them to relocate manufacturing activities to other or new facilities that are less affected by the outbreak.  In 2019, the average cost of dermal filler is USD 652/per injection, down from USD 652/per injection during COVID-19 due to lower demand.

Players Covered in Hyaluronic Acid-based Dermal Fillers Market are

• Sinclair Pharma (UK)
• ALLERGAN (Ireland)
• Merz Pharma (Germany)
• Suneva Medical (US)
• Galderma Laboratories (Canada)
• BioPlus Co.Ltd. (South Korea)
• Revance Therapeutics Inc (US)
• Bioxis pharmaceuticals (France)
• DR. Korman (Israel)
• Prollenium Medical Technologies (Canada)
• Anika Therapeutics Inc (US)
• SCULPT Luxury Dermal Fillers LTD (Czechia Republic)
• CANDELA CORPORATION (US)and other major players.

Key Industry Developments In Hyaluronic Acid-based Dermal Fillers Market

• In January 2023, Allergan Aesthetics (AbbVie, Inc.) announced the FDA approval of JUVÉDERM VOLBELLA XC in adults over the age of 21 to improve infraorbital hollows. With this approval, the company continues the expansion of its treatment portfolio to effectively address the needs of patients.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Product
 3.2 By Application
 3.3 By End-User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  3.5.1 Drivers
  3.5.2 Restraints
  3.5.3 Opportunities
  3.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 4: Hyaluronic Acid-Based Dermal Fillers Market by Product
 4.1 Hyaluronic Acid-Based Dermal Fillers Market Overview Snapshot and Growth Engine
 4.2 Hyaluronic Acid-Based Dermal Fillers Market Overview
 4.3 Single Phase
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size (2016-2028F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Single Phase: Grographic Segmentation
 4.4 Duplex
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size (2016-2028F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Duplex: Grographic Segmentation

Chapter 5: Hyaluronic Acid-Based Dermal Fillers Market by Application
 5.1 Hyaluronic Acid-Based Dermal Fillers Market Overview Snapshot and Growth Engine
 5.2 Hyaluronic Acid-Based Dermal Fillers Market Overview
 5.3 Cheek Augmentation
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Cheek Augmentation: Grographic Segmentation
 5.4 Lip Augmentation
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Lip Augmentation: Grographic Segmentation
 5.5 Wrinkle Correction
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Wrinkle Correction: Grographic Segmentation
 5.6 Nasolabial Folds
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Nasolabial Folds: Grographic Segmentation
 5.7 Scar Treatment
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Scar Treatment: Grographic Segmentation
 5.8 Restoration of Volume
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size (2016-2028F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Restoration of Volume: Grographic Segmentation
 5.9 Others
  5.9.1 Introduction and Market Overview
  5.9.2 Historic and Forecasted Market Size (2016-2028F)
  5.9.3 Key Market Trends, Growth Factors and Opportunities
  5.9.4 Others: Grographic Segmentation

Chapter 6: Hyaluronic Acid-Based Dermal Fillers Market by End-User
 6.1 Hyaluronic Acid-Based Dermal Fillers Market Overview Snapshot and Growth Engine
 6.2 Hyaluronic Acid-Based Dermal Fillers Market Overview
 6.3 Specialty & Dermatology Clinics
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Specialty & Dermatology Clinics: Grographic Segmentation
 6.4 Hospitals
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Hospitals: Grographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 Hyaluronic Acid-Based Dermal Fillers Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Ansoff Matrix
  7.1.5 Hyaluronic Acid-Based Dermal Fillers Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 Hyaluronic Acid-Based Dermal Fillers Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 SINCLAIR PHARMA (UK)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 ALLERGAN (IRELAND)
 7.4 MERZ PHARMA (GERMANY)
 7.5 SUNEVA MEDICAL (US)
 7.6 GALDERMA LABORATORIES (CANADA)
 7.7 BIOPLUS CO. LTD. (SOUTH KOREA)
 7.8 REVANCE THERAPEUTICS INC (US)
 7.9 BIOXIS PHARMACEUTICALS (FRANCE)
 7.10 DR. KORMAN (ISRAEL)
 7.11 PROLLENIUM MEDICAL TECHNOLOGIES (CANADA)
 7.12 ANIKA THERAPEUTICS INC (US)
 7.13 SCULPT LUXURY DERMAL FILLERS LTD (CZECHIA REPUBLIC)
 7.14 CANDELA CORPORATION (US)

Chapter 8: Global Hyaluronic Acid-Based Dermal Fillers Market Analysis, Insights and Forecast, 2016-2028
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Product
  8.2.1 Single Phase
  8.2.2 Duplex
 8.3 Historic and Forecasted Market Size By Application
  8.3.1 Cheek Augmentation
  8.3.2 Lip Augmentation
  8.3.3 Wrinkle Correction
  8.3.4 Nasolabial Folds
  8.3.5 Scar Treatment
  8.3.6 Restoration of Volume
  8.3.7 Others
 8.4 Historic and Forecasted Market Size By End-User
  8.4.1 Specialty & Dermatology Clinics
  8.4.2 Hospitals

Chapter 9: North America Hyaluronic Acid-Based Dermal Fillers Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Product
  9.4.1 Single Phase
  9.4.2 Duplex
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 Cheek Augmentation
  9.5.2 Lip Augmentation
  9.5.3 Wrinkle Correction
  9.5.4 Nasolabial Folds
  9.5.5 Scar Treatment
  9.5.6 Restoration of Volume
  9.5.7 Others
 9.6 Historic and Forecasted Market Size By End-User
  9.6.1 Specialty & Dermatology Clinics
  9.6.2 Hospitals
 9.7 Historic and Forecast Market Size by Country
  9.7.1 U.S.
  9.7.2 Canada
  9.7.3 Mexico

Chapter 10: Europe Hyaluronic Acid-Based Dermal Fillers Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Product
  10.4.1 Single Phase
  10.4.2 Duplex
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Cheek Augmentation
  10.5.2 Lip Augmentation
  10.5.3 Wrinkle Correction
  10.5.4 Nasolabial Folds
  10.5.5 Scar Treatment
  10.5.6 Restoration of Volume
  10.5.7 Others
 10.6 Historic and Forecasted Market Size By End-User
  10.6.1 Specialty & Dermatology Clinics
  10.6.2 Hospitals
 10.7 Historic and Forecast Market Size by Country
  10.7.1 Germany
  10.7.2 U.K.
  10.7.3 France
  10.7.4 Italy
  10.7.5 Russia
  10.7.6 Spain

Chapter 11: Asia-Pacific Hyaluronic Acid-Based Dermal Fillers Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Product
  11.4.1 Single Phase
  11.4.2 Duplex
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Cheek Augmentation
  11.5.2 Lip Augmentation
  11.5.3 Wrinkle Correction
  11.5.4 Nasolabial Folds
  11.5.5 Scar Treatment
  11.5.6 Restoration of Volume
  11.5.7 Others
 11.6 Historic and Forecasted Market Size By End-User
  11.6.1 Specialty & Dermatology Clinics
  11.6.2 Hospitals
 11.7 Historic and Forecast Market Size by Country
  11.7.1 China
  11.7.2 India
  11.7.3 Japan
  11.7.4 Southeast Asia

Chapter 12: South America Hyaluronic Acid-Based Dermal Fillers Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Product
  12.4.1 Single Phase
  12.4.2 Duplex
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Cheek Augmentation
  12.5.2 Lip Augmentation
  12.5.3 Wrinkle Correction
  12.5.4 Nasolabial Folds
  12.5.5 Scar Treatment
  12.5.6 Restoration of Volume
  12.5.7 Others
 12.6 Historic and Forecasted Market Size By End-User
  12.6.1 Specialty & Dermatology Clinics
  12.6.2 Hospitals
 12.7 Historic and Forecast Market Size by Country
  12.7.1 Brazil
  12.7.2 Argentina

Chapter 13: Middle East & Africa Hyaluronic Acid-Based Dermal Fillers Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Product
  13.4.1 Single Phase
  13.4.2 Duplex
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Cheek Augmentation
  13.5.2 Lip Augmentation
  13.5.3 Wrinkle Correction
  13.5.4 Nasolabial Folds
  13.5.5 Scar Treatment
  13.5.6 Restoration of Volume
  13.5.7 Others
 13.6 Historic and Forecasted Market Size By End-User
  13.6.1 Specialty & Dermatology Clinics
  13.6.2 Hospitals
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Saudi Arabia
  13.7.2 South Africa

Chapter 14 Investment Analysis

Chapter 15 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. HYALURONIC ACID-BASED DERMAL FILLERS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. HYALURONIC ACID-BASED DERMAL FILLERS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. HYALURONIC ACID-BASED DERMAL FILLERS MARKET COMPETITIVE RIVALRY
TABLE 005. HYALURONIC ACID-BASED DERMAL FILLERS MARKET THREAT OF NEW ENTRANTS
TABLE 006. HYALURONIC ACID-BASED DERMAL FILLERS MARKET THREAT OF SUBSTITUTES
TABLE 007. HYALURONIC ACID-BASED DERMAL FILLERS MARKET BY PRODUCT
TABLE 008. SINGLE PHASE MARKET OVERVIEW (2016-2028)
TABLE 009. DUPLEX MARKET OVERVIEW (2016-2028)
TABLE 010. HYALURONIC ACID-BASED DERMAL FILLERS MARKET BY APPLICATION
TABLE 011. CHEEK AUGMENTATION MARKET OVERVIEW (2016-2028)
TABLE 012. LIP AUGMENTATION MARKET OVERVIEW (2016-2028)
TABLE 013. WRINKLE CORRECTION MARKET OVERVIEW (2016-2028)
TABLE 014. NASOLABIAL FOLDS MARKET OVERVIEW (2016-2028)
TABLE 015. SCAR TREATMENT MARKET OVERVIEW (2016-2028)
TABLE 016. RESTORATION OF VOLUME MARKET OVERVIEW (2016-2028)
TABLE 017. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 018. HYALURONIC ACID-BASED DERMAL FILLERS MARKET BY END-USER
TABLE 019. SPECIALTY & DERMATOLOGY CLINICS MARKET OVERVIEW (2016-2028)
TABLE 020. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 021. NORTH AMERICA HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY PRODUCT (2016-2028)
TABLE 022. NORTH AMERICA HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY APPLICATION (2016-2028)
TABLE 023. NORTH AMERICA HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY END-USER (2016-2028)
TABLE 024. N HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY COUNTRY (2016-2028)
TABLE 025. EUROPE HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY PRODUCT (2016-2028)
TABLE 026. EUROPE HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY APPLICATION (2016-2028)
TABLE 027. EUROPE HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY END-USER (2016-2028)
TABLE 028. HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY COUNTRY (2016-2028)
TABLE 029. ASIA PACIFIC HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY PRODUCT (2016-2028)
TABLE 030. ASIA PACIFIC HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY APPLICATION (2016-2028)
TABLE 031. ASIA PACIFIC HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY END-USER (2016-2028)
TABLE 032. HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY COUNTRY (2016-2028)
TABLE 033. MIDDLE EAST & AFRICA HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY PRODUCT (2016-2028)
TABLE 034. MIDDLE EAST & AFRICA HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY APPLICATION (2016-2028)
TABLE 035. MIDDLE EAST & AFRICA HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY END-USER (2016-2028)
TABLE 036. HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY COUNTRY (2016-2028)
TABLE 037. SOUTH AMERICA HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY PRODUCT (2016-2028)
TABLE 038. SOUTH AMERICA HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY APPLICATION (2016-2028)
TABLE 039. SOUTH AMERICA HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY END-USER (2016-2028)
TABLE 040. HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY COUNTRY (2016-2028)
TABLE 041. SINCLAIR PHARMA (UK): SNAPSHOT
TABLE 042. SINCLAIR PHARMA (UK): BUSINESS PERFORMANCE
TABLE 043. SINCLAIR PHARMA (UK): PRODUCT PORTFOLIO
TABLE 044. SINCLAIR PHARMA (UK): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. ALLERGAN (IRELAND): SNAPSHOT
TABLE 045. ALLERGAN (IRELAND): BUSINESS PERFORMANCE
TABLE 046. ALLERGAN (IRELAND): PRODUCT PORTFOLIO
TABLE 047. ALLERGAN (IRELAND): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. MERZ PHARMA (GERMANY): SNAPSHOT
TABLE 048. MERZ PHARMA (GERMANY): BUSINESS PERFORMANCE
TABLE 049. MERZ PHARMA (GERMANY): PRODUCT PORTFOLIO
TABLE 050. MERZ PHARMA (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. SUNEVA MEDICAL (US): SNAPSHOT
TABLE 051. SUNEVA MEDICAL (US): BUSINESS PERFORMANCE
TABLE 052. SUNEVA MEDICAL (US): PRODUCT PORTFOLIO
TABLE 053. SUNEVA MEDICAL (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. GALDERMA LABORATORIES (CANADA): SNAPSHOT
TABLE 054. GALDERMA LABORATORIES (CANADA): BUSINESS PERFORMANCE
TABLE 055. GALDERMA LABORATORIES (CANADA): PRODUCT PORTFOLIO
TABLE 056. GALDERMA LABORATORIES (CANADA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. BIOPLUS CO. LTD. (SOUTH KOREA): SNAPSHOT
TABLE 057. BIOPLUS CO. LTD. (SOUTH KOREA): BUSINESS PERFORMANCE
TABLE 058. BIOPLUS CO. LTD. (SOUTH KOREA): PRODUCT PORTFOLIO
TABLE 059. BIOPLUS CO. LTD. (SOUTH KOREA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. REVANCE THERAPEUTICS INC (US): SNAPSHOT
TABLE 060. REVANCE THERAPEUTICS INC (US): BUSINESS PERFORMANCE
TABLE 061. REVANCE THERAPEUTICS INC (US): PRODUCT PORTFOLIO
TABLE 062. REVANCE THERAPEUTICS INC (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. BIOXIS PHARMACEUTICALS (FRANCE): SNAPSHOT
TABLE 063. BIOXIS PHARMACEUTICALS (FRANCE): BUSINESS PERFORMANCE
TABLE 064. BIOXIS PHARMACEUTICALS (FRANCE): PRODUCT PORTFOLIO
TABLE 065. BIOXIS PHARMACEUTICALS (FRANCE): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. DR. KORMAN (ISRAEL): SNAPSHOT
TABLE 066. DR. KORMAN (ISRAEL): BUSINESS PERFORMANCE
TABLE 067. DR. KORMAN (ISRAEL): PRODUCT PORTFOLIO
TABLE 068. DR. KORMAN (ISRAEL): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. PROLLENIUM MEDICAL TECHNOLOGIES (CANADA): SNAPSHOT
TABLE 069. PROLLENIUM MEDICAL TECHNOLOGIES (CANADA): BUSINESS PERFORMANCE
TABLE 070. PROLLENIUM MEDICAL TECHNOLOGIES (CANADA): PRODUCT PORTFOLIO
TABLE 071. PROLLENIUM MEDICAL TECHNOLOGIES (CANADA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. ANIKA THERAPEUTICS INC (US): SNAPSHOT
TABLE 072. ANIKA THERAPEUTICS INC (US): BUSINESS PERFORMANCE
TABLE 073. ANIKA THERAPEUTICS INC (US): PRODUCT PORTFOLIO
TABLE 074. ANIKA THERAPEUTICS INC (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. SCULPT LUXURY DERMAL FILLERS LTD (CZECHIA REPUBLIC): SNAPSHOT
TABLE 075. SCULPT LUXURY DERMAL FILLERS LTD (CZECHIA REPUBLIC): BUSINESS PERFORMANCE
TABLE 076. SCULPT LUXURY DERMAL FILLERS LTD (CZECHIA REPUBLIC): PRODUCT PORTFOLIO
TABLE 077. SCULPT LUXURY DERMAL FILLERS LTD (CZECHIA REPUBLIC): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 077. CANDELA CORPORATION (US): SNAPSHOT
TABLE 078. CANDELA CORPORATION (US): BUSINESS PERFORMANCE
TABLE 079. CANDELA CORPORATION (US): PRODUCT PORTFOLIO
TABLE 080. CANDELA CORPORATION (US): KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. HYALURONIC ACID-BASED DERMAL FILLERS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. HYALURONIC ACID-BASED DERMAL FILLERS MARKET OVERVIEW BY PRODUCT
FIGURE 012. SINGLE PHASE MARKET OVERVIEW (2016-2028)
FIGURE 013. DUPLEX MARKET OVERVIEW (2016-2028)
FIGURE 014. HYALURONIC ACID-BASED DERMAL FILLERS MARKET OVERVIEW BY APPLICATION
FIGURE 015. CHEEK AUGMENTATION MARKET OVERVIEW (2016-2028)
FIGURE 016. LIP AUGMENTATION MARKET OVERVIEW (2016-2028)
FIGURE 017. WRINKLE CORRECTION MARKET OVERVIEW (2016-2028)
FIGURE 018. NASOLABIAL FOLDS MARKET OVERVIEW (2016-2028)
FIGURE 019. SCAR TREATMENT MARKET OVERVIEW (2016-2028)
FIGURE 020. RESTORATION OF VOLUME MARKET OVERVIEW (2016-2028)
FIGURE 021. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 022. HYALURONIC ACID-BASED DERMAL FILLERS MARKET OVERVIEW BY END-USER
FIGURE 023. SPECIALTY & DERMATOLOGY CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 024. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 025. NORTH AMERICA HYALURONIC ACID-BASED DERMAL FILLERS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. EUROPE HYALURONIC ACID-BASED DERMAL FILLERS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. ASIA PACIFIC HYALURONIC ACID-BASED DERMAL FILLERS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. MIDDLE EAST & AFRICA HYALURONIC ACID-BASED DERMAL FILLERS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. SOUTH AMERICA HYALURONIC ACID-BASED DERMAL FILLERS MARKET OVERVIEW BY COUNTRY (2016-2028)